Literature DB >> 25101483

Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study.

Tze-Fan Chao1, Yen-Chang Huang2, Chia-Jen Liu3, Su-Jung Chen4, Kang-Ling Wang1, Yenn-Jiang Lin1, Shih-Lin Chang1, Li-Wei Lo1, Yu-Feng Hu1, Ta-Chuan Tuan1, Tzeng-Ji Chen5, Ming-Hsiung Hsieh6, Gregory Y H Lip7, Shih-Ann Chen8.   

Abstract

BACKGROUND: The risk of acute myocardial infarction (AMI) in patients with atrial fibrillation (AF) with a CHA2DS2-VASc score of 0 (for men) or 1 (for women) has not been previously investigated.
OBJECTIVE: The objective of the present study was to compare the risk of AMI in AF and non-AF subjects with a low (0 or 1) CHA2DS2-VASc score.
METHODS: By using the National Health Insurance Research Database in Taiwan, we identified 7254 men with AF (with a CHA2DS2-VASc score of 0) and 4860 women with AF (with a CHA2DS2-VASc score of 1). For each study patient, 1 age-, sex-, and CHA2DS2-VASc score-matched subject without AF was randomly selected to constitute the control group (n = 12,114). The clinical end point was the occurrence of AMI.
RESULTS: During a mean follow-up period of 5.7 ± 3.6 years, 258 patients (1.1%) suffered an AMI, with an annual incidence of 0.29% and 0.10% for patients with and without AF. AF was an independent risk factor of AMI, with an adjusted hazard ratio (HR) of 2.93 (95% confidence interval 2.21-3.87; P < .001). The risk of AMI was higher in men with AF than in women with AF, with a hazard ratio of 2.24 (95% confidence interval 1.61-3.11; P < .001) after adjustment for age and other comorbidities.
CONCLUSION: In patients with a CHA2DS2-VASc score of 0 or 1, AF was an independent risk factor of AMI. The risk of AMI was higher in men with AF than in women with AF. Cardiovascular risk prevention should be performed as part of the holistic management of AF to minimize the risks of AMI associated with AF.
Copyright © 2014 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; CHA(2)DS(2)-VASc score; Gender; Myocardial infarction; Subclinical atherosclerosis

Mesh:

Year:  2014        PMID: 25101483     DOI: 10.1016/j.hrthm.2014.08.003

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  19 in total

Review 1.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis.

Authors:  Darae Ko; Faisal Rahman; Renate B Schnabel; Xiaoyan Yin; Emelia J Benjamin; Ingrid E Christophersen
Journal:  Nat Rev Cardiol       Date:  2016-04-07       Impact factor: 32.419

2.  A Review of the Relationship of Atrial Fibrillation and Acute Coronary Syndrome.

Authors:  Bory Kea; Tahroma Alligood; Vincent Manning; Merritt Raitt
Journal:  Curr Emerg Hosp Med Rep       Date:  2016-07-06

3.  Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHAT.

Authors:  L Julian Haywood; Barry R Davis; Linda B Piller; William C Cushman; Jeffrey A Cutler; Charles E Ford; Lara M Simpson; Alokananda Ghosh; Elsayed Z Soliman; Jackson T Wright
Journal:  J Natl Med Assoc       Date:  2017-03-18       Impact factor: 1.798

4.  The Biomarkers NT-proBNP and CA-125 are Elevated in Patients with Idiopathic Atrial Fibrillation.

Authors:  Elton Amp Dudink; Bob Weijs; Samantha Tull; Justin Glm Luermans; Larissa Fabritz; Winnie Chua; Michiel Rienstra; Isabelle C Van Gelder; Ulrich Schotten; Paulus Kirchhof; Harry Jgm Crijns
Journal:  J Atr Fibrillation       Date:  2018-12-31

5.  The Impact of Cancer on Major Bleeding and Stroke/Systemic Emboli in Patients Using Direct Oral Anticoagulants:From the Database of a Single-Center Registry.

Authors:  Takao Sato; Yoshifusa Aizawa; Koichi Fuse; Satoshi Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masaaki Okabe
Journal:  J Atr Fibrillation       Date:  2018-12-31

6.  European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation.

Authors:  Cheng-Hung Li; Chia-Jen Liu; Annie Y Chou; Tze-Fan Chao; Ta-Chuan Tuan; Su-Jung Chen; Kang-Ling Wang; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Fa-Po Chung; Jo-Nan Liao; Tzeng-Ji Chen; Tsu-Juey Wu; Shih-Ann Chen
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

7.  Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation: A nationwide cohort study.

Authors:  Annie Y Chou; Chia-Jen Liu; Tze-Fan Chao; Kang-Ling Wang; Ta-Chuan Tuan; Tzeng-Ji Chen; Shih-Ann Chen
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  California Study of Ablation for Atrial Fibrillation:Re-hospitalization for Cardiac Events (CAABL-CE).

Authors:  Uma N Srivatsa; Guibo Xing; Ezra Amsterdam; Nipavan Chiamvimonvat; Nayereh Pezeshkian; Dali Fan; Richard H White
Journal:  J Atr Fibrillation       Date:  2018-06-30

Review 9.  Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.

Authors:  Francesco Violi; Elsayed Z Soliman; Pasquale Pignatelli; Daniele Pastori
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

10.  Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study.

Authors:  Hye Young Lee; Pil-Sung Yang; Tae-Hoon Kim; Jae-Sun Uhm; Hui-Nam Pak; Moon-Hyoung Lee; Boyoung Joung
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.